Targeting Drug Delivery to the Lungs by Inhalation

por O'Callaghan, C.
Publicado 1994

Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis

por Lazarus, B., John, G. T., O’Callaghan, C., Ranganathan, D.
Publicado 2016

Towards gene therapy for primary ciliary dyskinesia

por Munye, M, Hirst, RA, O'Callaghan, C, Howe, SJ, Hart, SL
Publicado 2012

The Canine POMC Gene, Obesity in Labrador Retrievers and Susceptibility to Diabetes Mellitus

por Davison, L.J., Holder, A., Catchpole, B., O'Callaghan, C.A.
Publicado 2017

Case series: Psychosocial challenges of female youth within the Irish travelling community

por O’ Neill, E., Abdul-Razak, N., Anastasova, Z., O’ Callaghan, C.
Publicado 2022

Direct Visualization of Antigen-specific CD8(+)T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

por Callan, M.F.C., Tan, L., Annels, N., Ogg, G.S., Wilson, J.D.K., O'Callaghan, C.A., Steven, N., McMichael, A.J., Rickinson, A.B.
Publicado 1998

Phenotypic variability of CCDC103 mutation in British Pakistani children with Primary Ciliary Dyskinesia (PCD)

por Robson, E, Moya, E, Burgoyne, T, Chetcuti, P, Dixon, M, Hirst, R, Hogg, C, Mitchison, H, O'Callaghan, C, Onoufriadis, A, Patel, M, Rutman, A, Sheridan, E, Shoemark, A
Publicado 2015

Innovative estimation of survival using log-normal survival modelling on ACCENT database

por Chapman, J W, O'Callaghan, C J, Hu, N, Ding, K, Yothers, G A, Catalano, P J, Shi, Q, Gray, R G, O'Connell, M J, Sargent, D J
Publicado 2013

Mutations in the dynein assembly factor PF22 (DNAAF3) cause primary ciliary dyskinesia with absent dynein arms

por Schmidts, M, Freshour, J, Loges, NT, Dritsoula, A, Antony, D, Hirst, RA, O’Callaghan, C, Blau, H, Olbrich, H, Yagi, T, Mussaffi, H, Chung, EMK, Omran, H, Mitchell, DR, Mitchison, H
Publicado 2012

Mutations in CCDC39 and CCDC40 are a major cause of primary ciliary dyskinesia with microtubule disorganisation

por Antony, D, Becker-Heck, A, Forouhan, M, Schmidts, M, Onoufriadis, A, Shoemark, A, Dixon, M, Jackson, C, Goggin, P, Olbrich, H, O’Callaghan, C, Lucas, J, Hogg, C, Chung, EMK, Omran, H, Mitchison, HM
Publicado 2012

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

por Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S
Publicado 2014

Tissue‐Engineered Tracheal Replacement in a Child: A 4‐Year Follow‐Up Study

por Hamilton, N. J., Kanani, M., Roebuck, D. J., Hewitt, R. J., Cetto, R., Culme‐Seymour, E. J., Toll, E., Bates, A. J., Comerford, A. P., McLaren, C. A., Butler, C. R., Crowley, C., McIntyre, D., Sebire, N. J., Janes, S. M., O'Callaghan, C., Mason, C., De Coppi, P., Lowdell, M. W., Elliott, M. J., Birchall, M. A.
Publicado 2015

Gene discovery for motile cilia disorders: mutation spectrum in primary ciliary dyskinesia and discovery of mutations in CCDC151

por Onoufriadis, A, Hjeij, R, Watson, CM, Slagle, CE, Klena, NT, Dougherty, GW, Kurkowiak, M, Loges, NT, Diggle, CP, Morante, NF, Gabriel, GC, Lemke, KL, Li, Y, Pennekamp, P, Menchen, T, Marthin, JK, Mans, D, Letteboer, SJ, Werner, C, Burgoyne, T, Westermann, C, Rutman, A, Carr, IM, O'Callaghan, C, Moya, E, Chung, EMK, Sheridan, E, Nielsen, KG, Roepman, R, Burdine, RD, Lo, CW, Omran, H, Mitchison, H
Publicado 2015